Skip to content

13F-HR filed by NOVO HOLDINGS A/S

NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 52 holding rows worth $2,097,261,000.

Accession
0000950123-22-011721
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 52 entries on the cover page, a total value of $2,097,261,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,097,264,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VTI922908769COM1,525,550$500,838,000thousands by filing date
Stryker Corporation863667101COM796,941$161,412,000thousands by filing date
CATALENT INC USD 0.01148806102COM1,632,878$118,155,000thousands by filing date
BROOKFIELD ASSET MANAGEMENT IN112585104CL A LTD VT SH2,508,830$102,586,000thousands by filing date
ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHSN07059210STOK226,770$94,189,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM3,327,768$85,324,000thousands by filing date
Salesforce.com, Inc79466L302COM578,500$83,211,000thousands by filing date
STERIS PLC SHS USDG8473T100Stock467,687$77,767,000thousands by filing date
Boston Scientific Corporation101137107COM1,762,942$68,279,000thousands by filing date
CABLE ONE INC12685J105COM80,023$68,264,000thousands by filing date
Apple Inc037833100COM461,379$63,763,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock3,191,878$59,912,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM6,071,703$59,746,000thousands by filing date
TAIWAN SEMICONDUCTOR MFG874039100SPONSORED ADS710,780$48,731,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS500,827$40,061,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM1,684,193$35,385,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM911,111$31,297,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM317,500$26,914,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,100,000$21,924,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM316,674$20,866,000thousands by filing date
VECTIVBIO HLDG AGH9060V101COM3,339,484$20,037,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock100,000$20,016,000thousands by filing date
VAXCYTE INC COM92243G108Stock823,705$19,769,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM2,000,000$18,380,000thousands by filing date
MINERVA SURGICAL INC60343F106COM1,862,877$17,194,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock770,000$16,586,000thousands by filing date
INARI MED INC45332Y109COM213,200$15,487,000thousands by filing date
LAVA THERAPEUTICS NVN51517105SHS3,327,312$15,206,000thousands by filing date
TREACE MED CONCEPTS INC89455T109COM588,308$12,984,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock631,627$12,405,000thousands by filing date
SILK ROAD MEDICAL INC82710M100COMMON STOCK275,511$12,398,000thousands by filing date
RENEO PHARMACEUTICALS INC75974E103COM3,430,377$11,492,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock1,126,915$11,145,000thousands by filing date
NKARTA INC65487U108COMMON STOCK823,200$10,833,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock60,900$10,802,000thousands by filing date
SEAGEN INC81181C104COM75,000$10,262,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM632,822$10,100,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM815,707$9,748,000thousands by filing date
RALLYBIO CORP75120L100COM630,921$9,129,000thousands by filing date
IO BIOTECH INC449778109COM3,277,932$8,883,000thousands by filing date
PULMONX CORP745848101COM510,555$8,506,000thousands by filing date
CYTEIR THERAPEUTICS INC23284P103COMMON3,940,413$7,566,000thousands by filing date
SPRUCE BIOSCIENCES INC85209E109COM4,514,336$6,185,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM3,703,991$5,482,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM598,377$5,152,000thousands by filing date
GALECTO INC36322Q107COM2,497,791$4,721,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK610,000$4,679,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK2,459,021$4,279,000thousands by filing date
MARQETA INC57142B104CLASS A COM441,558$3,144,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM525,867$2,987,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock1,950,000$2,145,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM468,902$938,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-011721this filing2022-11-14acceptance time not in the bulk data set